Research Article110.1016/0924-977x(92)90133-sPhase I study of single ascending doses of befloxatone, a new reversible MAO-A inhibitor antidepressantSep 01, 1992European NeuropsychopharmacologyM Ansseau + 9 more +9RelevantCiteListenSave